CHUM/Université de Montréal
Montreal, Quebec, H2X 0A9, Canada
Location status: Recruiting
NCT Number: NCT06161636
The working hypotheses are as follows: #1 The processing of performance signals by automated lognormal segmentation and the extraction of the parameters of interest will make it possible to distinguish groups of patients from healthy elderly subjects. #2 The three instrumental approaches will not have the same degree of reliability as a predictive biomarker of clinical diagnosis established by consensus.
Interested in participating?
Request Info50 year–75 year
All sexes
Observational
Montreal, Quebec, H2X 0A9, Canada
Location status: Recruiting
The strength of this study is to compares three refined parametric approaches drawn from functions mediated by very different neuromuscular programs (visually guided voluntary movement control to perform trajectories with the hand or arm versus vocal control) among two groups of patients and a healthy group. Its weakness lies in the lack of multimodal methods to accurately confirm clinical diagnosis and the predictive reliability of patient performance. These modalities are too costly to be included in this project. However, different oculovisual measurement standards such as optical coherence tomography, hyperspectral imaging (OPTINA Diagnostics Inc.), and eye tracking will be used at the School of Optometry, University of Montreal. There is indeed a remodeling of the retina and oculomotor changes in Parkinson's Disease (PD) and these non-invasive techniques, which have been accepted for several years, will be used in patients in support of their clinical diagnosis compared to normal subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1
Velocity profiles generated for simple movements (strokes) and certain vocal frequencies (formants), transformed to fit into the lognormal model
Time frame: Day 1
Measures of thickness for macula, fovea, peripapillary retinal nerve fiber layer, divided in quadrants, expressed in microns.
Time frame: Day 1
Motor rating in the practically defined unmedicated state, in points
Time frame: Day 1
Clinical tool to evaluate perceived problems with speech, swallowing, and saliva in subjects with parkinsonism, in points
Contact information is provided by the study sponsor or research team.
Centre hospitalier de l'Université de Montréal (CHUM)
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07685873
Basal Ganglia Diseases, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT07674264
Basal Ganglia Diseases, Brain Diseases
Gainesville, Florida, United States
View Trial DetailsNCT07187843
Basal Ganglia Diseases, Brain Disease
Reggio Emilia, Italy
View Trial DetailsNCT07442370
Basal Ganglia Diseases, Brain Diseases
Istanbul, Sancaktepe, Turkey (Türkiye)
View Trial Details